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Abstract
Epstein-Barr virus (EBV) latent infection is a critical
event in nasopharyngeal carcinoma (NPC) tumori-
genesis. EBV-encoded genes have been shown to be
involved in immune evasion and in the regulation of
various cellular signaling cascades. To elucidate the
roles of EBV in NPC development, stable infection of
EBV in nasopharyngeal epithelial cell lines was estab-
lished. Similar to primary tumors of NPC, these in-
fected cells exhibited a type II EBV latency expression
pattern. In this study, multiple cellular signaling path-
ways in EBV-infected cells were investigated. We first
demonstrated that in vitro EBV infection resulted in
the activation of STAT3 and NFKB signal cascades in
nasopharyngeal epithelial cells. Increased expression
of their downstream targets (c-Myc, Bcl-xL, IL-6, LIF,
SOCS-1, SOCS-3, VEGF, and COX-2) was also observed.
Moreover, EBV latent infection induced the suppression
of p38-MAPK activities, but did not activate PKR cas-
cade. Our findings suggest that EBV latent infection is
able to manipulate multiple cellular signal cascades to
protect infected cells from immunologic attack and to
facilitate cancer development.
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Introduction
Nasopharyngeal carcinoma (NPC) is one of the most pre-
valent types of cancers in southern China and Southeast
Asia. More than 50,000 new NPC cases are reported
each year in these regions [1]. In contrast to other head
and neck cancers, the unique feature of NPC is its close
association with Epstein-Barr virus (EBV). Serologic and
molecular studies have suggested that EBV may play a
contributory role in NPC tumorigenesis. Notably, in high-grade
precancerous lesions and in invasive carcinoma of the naso-
pharynx in the abovementioned regions, a clonal EBV genome
is consistently detected [1]. All EBV-infected NPC cells exhibit
type II latency, with expression of EBV-encoded small RNA
(EBER), EBV-associated nuclear antigen-1 (EBNA1), latent
membrane protein 1/2 (LMP1 and LMP2), BamHI A RNA tran-
scripts (BART), andBARF1protein [1,2]. EBV is considered tobe
an oncogenic virus, owing to its ability to immortalize and
transform primary cells in vitro [2]. Among EBV latent proteins,
LMP1 and BARF1 have been reported to be able to transform B
lymphocytes, fibroblasts, or epithelial cells in vitro [2,3]. LMP2
has been shown to mediate B-lymphocyte survival, to transform
epithelial cells, and to inhibit cell differentiation [4,5]. EBNA1 and
EBER, which are expressed in all types of EBV latency, have
been proposed to play roles in immune evasion [3,6]. Further-
more, almost all of the EBV latent gene–encoded products are
able to interact with different cellular signal proteins, suggesting
the involvement of EBV latent infection in manipulating parts of
a host’s cellular programs [1,3,6].
In vitro, EBV can infect and efficiently transform B lympho-
cytes, providing a system to study the interaction of EBV with B
cells [2]. In contrast, most epithelial cells are not susceptible to
EBV infection in cell culture systems [7]. In addition, deriving
Abbreviations: NPC, nasopharyngeal carcinoma; EBV, Epstein-Barr virus; IFN, interferon
Address all correspondence to: Kwok Wai Lo, Department of Anatomical and Cellular
Pathology, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, NT, Hong
Kong SAR, China. E-mail: kwlo@cuhk.edu.hk
1This work was completed under the supervision and support of Dolly P. Huang, who passed
on recently. This work was supported by the Kadoorie Charitable Foundations and the Hong
Kong Research Grant Council (central allocation: HKUST 2/03C). A. K. F. Lo is a postdoctoral
fellow supported by a Croucher Foundation Fellowship (Hong Kong).
Received 22 September 2005; Revised 29 December 2005; Accepted 3 January 2006.
Copyright D 2006 Neoplasia Press, Inc. All rights reserved 1522-8002/06/$25.00
DOI 10.1593/neo.05625
Neoplasia . Vol. 8, No. 3, March 2006, pp. 173 –180 173
www.neoplasia.com
RESEARCH ARTICLE
stable EBV-positive cell lines from carcinoma tissues has
been largely disappointing, owing to the loss of EBV
genomes during cell line establishment [8]. Lack of suitable
EBV-infected epithelial cell lines leads to poor understanding
of the impact of EBV latent infection on cellular signaling
cascades in human nasopharyngeal epithelial cells.
In this study, persistent EBV latent infection in malignant
or immortalized nasopharyngeal epithelial cell lines was es-
tablished with a recombinant EBV (rEBV) carrying a neo-
mycin resistance (neor ) gene and a green fluorescent protein
(EGFP) gene. We also demonstrated that cellular signaling
was altered by EBV in nasopharyngeal epithelial cells.
Materials and Methods
Cell Lines
NPC cell lines HK1 and C666-1 were routinely maintained
in RPMI 1640 supplemented with 10% fetal bovine serum
(FBS) [9,10]. TheNP69,NP69-pLNSX,andNP69-LMP1naso-
pharyngeal epithelial cell lines were grown in keratinocyte–
SFM medium (Invitrogen, Carlsbad, CA) [11,12].
EBV Infection
Before infection, the EGFP-neorEBV–infected Akata cells
were induced for the production of infectious rEBV by sur-
face IgG cross-linking [13]. First, dialyzed anti-human IgG
goat serum was added to a cell suspension (5  106 ml1)
to give a final concentration of 0.8 % (vol/vol). The cells
were then incubated in RPMI medium with 3% FBS at 37jC
for 4 hours with shaking. After sIgG cross-linking, 1 ml of
EGFP-neorEBV–infected Akata cell suspension was added
to the target cells, which were maintained in a T25 flask with
3 ml of fresh medium. Both cultures were then incubated
for 2 to 6 days at 37jC in 5% CO2, with replacement of half
of the medium after every 2 days of incubation. After com-
pletion of the infection step, cocultivated cultures were
thoroughly washed four times with phosphate-buffered sa-
line to remove residual viable Akata cells, and 3 ml of fresh
medium was added. One day after infection, the cells were
fed medium containing 50 to 500 mg/ml G418 for EBV-
positive cell selection. After 2 to 3 weeks of selection, EBV-
positive cells were observed to be green under a fluorescent
microscope. The EBV-positive cells were then maintained in
drug-free medium, and G418 treatment was performed only
after every three to four subcultures to prevent the genera-
tion of drug-resistant EBV-negative cells. After subculture for
20 passages, the majority of the cells was still green,
indicating the presence of EBV in the cells. All the experi-
ments were then performed between passages 21 and 25.
The cells were fed serum-free medium for 12 hours before
cell signal pathway analyses to eliminate the influence of
serum on cellular signaling.
In Situ Hybridization (ISH)
Detection of EBER (EBER-1 and EBER-2) was carried
out with an EBV Probe ISH Kit (Novocastra, Newcastle, UK),
as previously described [14].
Semiquantitative Reverse Transcription Polymerase Chain
Reaction (RT-PCR)
First-strand cDNAwas synthesized from 5 mg of total RNA
with oligo-dT primer and SuperScript II reverse transcrip-
tase (Invitrogen) followed by PCR amplification using gene-
specific primers listed in Table 1. To collect PCR products at
the linear range, the number of PCR cycles was optimized for
each primer set. For the detection of each specific gene, in-
dependent RT-PCR reactions were performed in duplicate
using different sets of RNA samples as templates.
Indirect Immunofluorescence Assay
Cells for immunofluorescence assay were cultured in a
slide chamber (Coster, Cambridge, MA) for 2 days and then
were fixed with 100% methanol, in which the EGFP fluores-
cent signal of EBV-infected cells is destroyed. Immunostaining
was performed by standard procedures. Antibodies against
STAT3 were obtained from Cell Signaling, Danvers, MA.
Western Blot Analysis and Immunohistochemistry Analysis
A detailed procedure of Western blot analysis has been
previously described [15]. Briefly, the cells were lysed in cell
lysis buffer (Cell Signaling). The cell lysates (25–100 mg of
protein) were separated in 10% sodium dodecyl sulfate poly-
acrylamide gel electrophoresis and then electrophoretically
transferred to nitrocellulose membranes (Bio-Rad, Hercules,
CA) for blotting. To investigate the expression of activated
STAT3 in primary undifferentiated NPCs, immunohisto-
chemistry analysis of 24 formalin-fixed paraffin-embedded
Table 1. Oligonucleotide Primers Used in RT-PCR Analysis.
Transcript Primer Oligonucleotide Sequence
EBER1 5V AGG ACC TAC GCT GCC CTA GA
3V AAA ACA TGC GGA CCA CCA GC
Q-EBNA1 5V GTG CGC TAC CGG ATG GCG
Y3-EBNA1 5V TGG CGT GTG ACG TGG TGT AA
K-EBNA1 3V GCT CCT GTT CCA CCG TGG GT
EBNA2 5V GCT GCT ACG CAT TAG AGA CC
3V TCC TGG TAG GGA TTC GAG GG
LMP1 5V AGC GAC TCT GCT GGA AAT GAT
3V TGA TTA GCT AAG GCA TTC CCA
LMP2a 5V ATG ACT CAT CTC AAC ACA TA
LMP2b 5V CAG TGT AAT CTG CAC AAA GA
LMP2 3V CAT GTT AGG CAA ATT GCA AA
BARF1 5V CAG GTT CAT CGC TCA GCT CC
3V CAT GGG AGA TGT TGG CAG C
BamHIA 5V AGA GAC CAG GCT GCT AAA CA
3V AAC CAG CTT TCC TTT CCG AG
BZLF1 5V TTC CAC AGC CTG CAC CAG TG
3V GGC AGC AGC CAC CTC ACG GT
BRLF1 5V GAC CAA GCT ACC AGA GTC TAT
3V CAG AAT CGC ATT CCT CCA GCG A
CD19 5V CTG AGG ATG AGC CCC TGG GT
3V GCC CAT CGG GAT TAT CCA TGT
IL-6 5V TGG TGT TGC CTG CTG CCT TC
3V CTC ATC TGC ACA GCT CTG GC
LIF 5V GGC CCG GAC ACC CAT AGA CG
3V CCA CGC GCC ATC CAG GTA AA
SOCS-1 5V CAC GCA CTT CCG CAC ATT CC
3V TCC AGC AGC TCG AAG AGG CA
SOCS-3 5V CTC GCC ACC TAC TGA ACC CTC
3V AAG CGG GGC ATC GTA CTG GT
GAPDH 5V CTC AGA CAC CAT GGG GAA
3V ATG ATC TTG AGG CTG TTG
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sections of NPC cases was conducted by using anti –
phospho-STAT3 polyclonal antibody (Cell Signaling).
Electrophoretic Mobility Shift Assay (EMSA)
EMSA was performed according to the protocol of Gel
Shift Assay Systems (Promega, Madison, WI). Briefly, 10 mg
of nuclear proteins extracted by NE-PER Nuclear and Cyto-
plasmic Extraction reagents (Pierce, Rockford, IL) was incu-
bated with 32P-labeled NFnB consensus oligonucleotide
(Santa Cruz Biotechnology, Sta. Cruz, CA) for 20 minutes
at room temperature. After incubation, mixtures were sub-
jected to autoradiography and electrophoresis in a 5% poly-
acrylamide gel. Competition assay was performed with a
50-fold excess unlabeled NFnB consensus probe or a mutant
probe (Santa Cruz Biotechnology). Super gel shift assay was
performed with antibodies against NFnB-p65 and NFnB-p50
(Santa Cruz Biotechnology). Antibody against STAT3 (Santa
Cruz Biotechnology) was used as nonspecific antibody.
Results
Infection of Nasopharyngeal Epithelial Cell Lines
by EGFP-neorEBV
Direct cell-to-cell contact between EBV-producing B cells
(Akata) and target cells was recently shown to be highly ef-
ficient in the transmission of EBV into a variety of human
epithelial cells [7]. EBV transmission by cell-to-cell contact
occurs independently of the CR2 receptor that mediates
EBV entry into B cells [16]. In the present study, the SV40-
immortalized nasopharyngeal epithelial NP69 cell line and
the EBV-negative HK1 NPC cell line were subjected to EBV
infection by cocultivation with Akata B cells. The latter carries
an rEBV (EGFP-neorEBV) containing a neor gene and an
EGFP gene. The introduction of G418-resistant (neor ) and
EGFP genes into the EBV genome allows selective growth
of EBV-infected nasopharyngeal epithelial cells. After neo-
mycin selection, drug-resistant cells were obtained. Although
infection efficiencies were different between NP69 and HK1
cells, the cells with green fluorescence under fluorescent mi-
croscopy increased from passage 5 (Figure 1A) to passage
20 (Figure 1B) postinfection, indicating enrichment of the
EGFP-neorEBV population. A high percentage of the EBV-
positive cells was stably maintained in both NP69-EBV and
HK1-EBV lines after passage 20. Fluorescence-activated
cell sorter analysis at passage 23 postinfection demon-
strated that 87.45% of EBV-infected NP69 (NP69-EBV) cells
and 98.03% of HK-1 (HK1-EBV) cells were EBV-positive
(Figure 1C). ISH also confirmed the presence of EBER in
the majority of cells in these two EBV-infected cell lines
(Figure 2A). More than 85% of the cells showed expression
of EBER transcripts. The findings showed that direct cell-
to-cell contact was an efficient method for the establishment
of EBV-infected nasopharyngeal epithelial cells.
Figure 1. Detection of EGFP-neorEBV in nasopharyngeal epithelial cells. Neomycin-resistant cells at (A) passage 5 and at (B) passage 20 postinfection exhibited a
fluorescent signal under fluorescence microscopy, indicating EGFP-neorEBV infection (original magnification, 40). (C) Fluorescence-activated cell sorter analysis
of the EGFP expression of epithelial cells at passage 23 postinfection. Filled curves represent the fluorescence intensity of EBV-infected cells, whereas black lines
denote the fluorescence intensity of uninfected cells.
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EBV Infection of Nasopharyngeal Epithelial Cells Results
in Type II Latency
In addition to detecting EBER transcripts by ISH, we have
examined a latent gene expression pattern in two EBV-
infected nasopharyngeal epithelial cell lines (NP69-EBV
and HK1-EBV) by RT-PCR analysis (Figure 2B). B95.8 LCL
cells, Akata B cells carrying recombinant EGFP-neorEBV,
and C666-1 NPC cells were included as controls. The EBV-
infected nasopharyngeal epithelial cell lines (NP69-EBV and
HK1-EBV) expressed Qp-EBNA1, EBER-1, LMP1, LMP2A,
BART, and BARF1 genes, but not EBNA2 and Cp/Wp-
EBNA1. LMP2B was detected only in HK1-EBV cells, but
not in NP69-EBV cells. Expression of lytic BZLF1 and BRLF1
was negligible. These EBV expression patterns, especially
the characteristic Qp promoter usage, correspond to type II
latency infection and are similar to those of the EBV-positive
NPC cell line C666-1 and primary biopsies [1,10]. Lack of ex-
pression of the B-cell–specific maker CD19 in all G418-
resistant cell lines confirmed the absence of contaminating
Akata B cells (Figure 2B). In addition, LMP1 protein expres-
sion was examined in EBV-infected cells by Western blot
analysis. The EBV-positive NPC cell line C666-1 was in-
cluded as control. Similar to RT-PCR results in Figure 2B,
HK1-EBV cells exhibited strong levels of LMP1, whereas
NP69-EBV cells expressed a relatively low level (which was
still higher than that of C666-1 cells) (Figure 2C). As con-
trols, B95.8 cells were shown to exhibit a type III latency
expression pattern. They expressed BZLF1, BRLF1, and
almost all EBV latent genes. For EBNA1, only Cp/Wp pro-
moter activity was detected. In Akata GFP cells, we detected
the activity of the Qp promoter, but not of the Cp/Wp pro-
moter. However, expression of genes for type III latency
(e.g., EBNA2) and of lytic genes (BZLF1 and BRLF1) was
also seen. It is suspected that RT-PCR analysis may capture
a few cells that are in the lytic cycle.
Activation of STAT3 Pathway in Nasopharyngeal Epithelial
Cells by EBV Latent Infection
By immunofluorescent staining with STAT3-specific anti-
body in NP69 and HK1 cells with and without infection
(Figure 3A, upper panel ), the majority of STAT3 was de-
tected in the nucleus of EBV-infected cells, indicating the
Figure 2. EBV latency expression pattern in nasopharyngeal epithelial cells. (A) In situ RNA hybridization of EBER in EGFP-neorEBV– infected cells. (B)
Semiquantitative RT-PCR analysis of EBV-associated transcripts and CD19 in EBV-infected nasopharyngeal epithelial cells. GAPDH was used as loading control.
(C) Western blot analysis of LMP1 protein expression in EBV-infected cells.
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activation of STAT3. In uninfected cells, STAT3 was localized
in the cytoplasm, showing that STAT3 was inactive. No signal
was seen in the negative control lacking primary antibody
(Figure 3A, lower panel ), indicating the specificity of STAT3
immunofluorescent staining. For further confirmation, West-
ern blot analysis with antibodies specific to phospho-STAT3
(Tyr 705) and STAT3 (Ser 727) was performed. In addition
to NP69-EBV, HK1-EBV, and C666-1, the LMP1 expressing
NP69 cells (NP69-LMP1) and the empty vector pLNSX ex-
pressing NP69 cells (NP69-pLNSX) were also included for
analysis. Both HK1-EBV and NP69-EBV demonstrated a
strong expression of phospho-STAT3 when compared with
their EBV-negative counterparts (Figure 3B). The C666-1
and NP69-LMP1 cells also showed strong STAT3 activity.
The detection of STAT3 activation in NP69-LMP1 cells in-
dicated that LMP1 can activate STAT3 cascade. As STAT3
activation was highly increased in EBV latent infection in
nasopharyngeal epithelial cell lines, the finding suggests
that activation of STAT3 by EBV may be associated with
NPC pathogenesis. By using immunohistochemistry analy-
sis with antibody specific to phospho-STAT3, STAT3 acti-
vation was investigated in primary NPCs. Phospho-STAT3
was detectable in 17 of 24 (70.8%) tumors examined (Fig-
ure 3C). All of the 24 primary tumors were positive for
EBER ISH. No LMP1 protein was detected in seven pri-
mary tumors that showed no phospho-STAT3 staining. In
the present study, we also determined the expression of
STAT3-positive activators (including IL-6 and LIF) and
STAT3-negative activators (including SOCS-1 and SOCS-3)
by RT-PCR (Figure 3D). Increased expression of IL-6, LIF,
and SOCS-1 was observed in all EBV-infected cells, as well
as in NP69-LMP1 cells. Obvious induction of SOCS-3 was
Figure 3. Activation of STAT pathways in EBV-infected nasopharyngeal epithelial cells. (A ) Immunofluorescent staining with STAT3-specific antibody (original
magnification, 100; upper panel). Lower panel shows negative controls in which no primary antibody was added. (B) Western blot analysis of STAT3 activation
using phosphorylation-specific antibodies. Actin was included as loading control. (C) Immunohistochemical staining for phospo-STAT3. Left: Positive staining of
phospho-STAT3 was exhibited in two primary NPC samples (original magnification, 400). Right: A case of NPC showed negative staining of phospho-STAT3.
Positive staining of lymphocytes as internal positive control (original magnification, 400). (D) Expression of STAT3-associated genes in EBV-infected naso-
pharyngeal epithelial cells. Semiquantitative RT-PCR analysis of IL-6, LIF, SOCS-1, and SOCS-3.
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also detected in all EBV-positive cell lines, whereas the
NP69-LMP1 cells expressed lower levels of SOCS-3 relative
to the NP69-pLNSX cells.
Activation of NFnB Pathway in Nasopharyngeal Epithelial
Cells by EBV Latent Infection
In addition to the STAT pathway, we also examined the
effects of EBV latent infection on the proinflammatory NFnB
pathway by EMSA. Increased activation of NFnB was ob-
served in all cell lines with EBV infection (Figure 4A). Western
blot analysis also detected increased InB phosphorylation
in EBV-infected cell lines (Figure 4B) and in NP69-LMP1
cells, demonstrating that EBV could increase the activity
of NFnB signaling, possibly as a result of the effects of the
LMP1 protein. Otherwise, there was no significant change in
the total amounts of InB, p50-NFnB, and p65-NFnB proteins
after EBV infection, suggesting that EBV infection has no
effect on the expression of NFnB signaling proteins but
affects only NFnB activity (Figure 4B).
By Western blot analysis, we showed that the NFnB
downstream targets (COX-2 and VEGF) associated with
invasion and angiogenesis were upregulated in protein
levels in the NP69-LMP1 cell line and in all EBV-infected
cell lines (Figure 4C). Moreover, c-Myc and Bcl-xL, which
have been reported to be induced by STAT3 and NFnB, were
also increased in the NP69-EBV, HK1-EBV, C666-1, and
NP69-LMP1 cell lines (Figure 4C).
Effect of EBV Latent Infection on p38-MAPK
and PKR Pathways
To investigate the effects of EBV on signaling cascades
associated with immune response, we then examined
PKR signaling, which is one of the major pathways induced
after viral infection. However, levels of phospho-eIF-2a and
Figure 4. Effects of EBV latent infection on the NFjB pathway in nasopharyngeal epithelial cells. (A) EMSA showing the kinetics of NFjB binding activity in nuclear
extracts isolated from EBV-infected and uninfected cells (left panel). The specificity of binding was determined by competition experiments in which a nuclear
extract isolated from C666-1 cells was analyzed in the presence of a 50-fold excess of an unlabelled NFjB consensus probe or an NFjB mutant probe (right panel,
lanes 1–4). The activation of p50-NFjB and p65-NFjB complexes was examined by supershift analysis using antibodies against p50 and p65. Antibody against
STAT3 was used as negative control (right panel, lanes 5–8). (B) Western blot analysis of NFjB activity using antibody specific for the phosphorylated form of IjB.
The total levels of IjB, p50-NFjB, and p60-NFjB were also examined. (C) Western blot analysis of NFjB downstream targets (VEGF and COX-2) associated with
cell invasion, and of c-Myc and Bcl-xL in EBV-infected nasopharyngeal epithelial cells.
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phospho-PKR kinases had no significant change in EBV-
infected nasopharyngeal epithelial cells (Figure 5A). This
finding suggests that the PKR pathway failed to activate on
EBV latent infection. By investigating the p38-MAPK path-
way that is responsible for cytokine expression, we found
that the level of phospho-p38 MAPK was dramatically re-
duced in HK1 cells on EBV latent infection and that the
signal was undetectable in C666-1 EBV-positive NPC cells,
although their basal level of p38-MAPKwas clearly indicated.
We detected low levels of phospho-p38 MAPK in NP69
cells. No significant change of p38 MAPK phosphorylation
was found in EBV-infected NP69 cells (Figure 5B).
Discussion
The roles of EBV latent infection in the tumorigenesis of NPC
are of interest because of the close association of this virus
with NPC. However, owing to the limitations of the EBV-
positive nasopharyngeal epithelial cell model, the critical func-
tions of EBV in NPC development remain poorly understood.
By cocultivation with Akata B cells harboring rEBV, we estab-
lished a stable infection of EBV in both NP69 and HK-1 naso-
pharyngeal epithelial cell lines. The infected cells exhibited
a typical type II latent gene expression pattern. This is also
reminiscent of a specific EBV latency program in NPC pri-
mary tumors [1].
The current study is the first report of multiple cellular sig-
naling pathways being investigated in EBV-infected naso-
pharyngeal epithelial cells. In particular, activation of the
STAT3 and NFnB pathways is predominant. Upregulation
of their downstream targets was also demonstrated. More-
over, suppression of p38-MAPK signaling was demon-
strated in EBV latently infected nasopharyngeal cancer
cells, whereas PKR signal activity had no significant change.
STAT3 is a transcription factor that is activated by a num-
ber of ligands, including IL-6 and LIF. In response to the
binding of ligands to cytokine receptors, tyrosine residues on
STAT proteins are phosphorylated by Janus activated kinase
family kinases. The expression of IL-6 and LIF can also be
mediated by STAT3 activity [17]. Previous studies have
shown that LMP1 can increase the activity of STAT3 and
the expression of IL-6 [18]. Here, we showed that EBV in-
fection and expression of LMP1 could activate STAT3 sig-
naling and increase the expression IL-6 and LIF. These
findings suggest that the expression of LMP1 in EBV latently
infected epithelial cells is able to activate STAT3 signal cas-
cade. Moreover, the expression of IL-6 and LIF mediated
by LMP1 may generate a positive feedback loop to per-
sistently activate STAT3. Constitutive activation of STAT3
has been found in a variety of malignancies, including NPC
[19,20]. In the present study, we also demonstrated that con-
stitutive activation of STAT3 was common in primary tumors
of NPC. Because clonal EBV genomes and LMP1 expression
are detected in high-grade preinvasive lesions and invasive
carcinomas, EBVmay play a critical role in transforming naso-
pharyngeal epithelial cells through activation of STAT3 signal-
ing [1]. Aside from the STAT3 pathway, we found that NFnB
signaling was activated in EBV latently infected nasopharyn-
geal epithelial cells. Therefore, increased expression of
VEGF, COX-2, c-Myc, and Bcl-xL in EBV-infected cells is
possibly related to the activation ofNFnBandSTAT3 signaling
[21,22]. By upregulating the apoptosis suppressor Bcl-xL and
the cell cycle activator c-Myc, EBV latent infection may medi-
ate cell growth and prevent the apoptosis of nasopharyngeal
epithelial cells. Moreover, activation of STAT3 was found to
be required for de novo epithelial carcinogenesis, by main-
taining the survival of DNA-damaged stem cells and me-
diating the proliferation necessary for clonal expansion of
initiated cells during tumor promotion [23]. Furthermore, both
VEGF and COX-2 are potent angiogenic factors; an associ-
ation of VEGF with metastatic NPC has been reported [24].
Induction of COX-2 and VEGF by EBV may therefore play a
role in angiogenesis of NPC.
It has been noted that the EBV genome is commonly lost
during the establishment of NPC cell lines from biopsies or
xenografts, implying that, unlike in vivo growth, EBV is not
necessary for maintaining the growth of carcinoma cells
in vitro [8]. This observation suggests that EBV may have
other important roles in vivo, which may include, but are not
limited to, conferring protection to the carcinoma cells from
immune surveillance. Previous studies from other workers
have shown that STAT3 can inhibit inflammation in various
cell types [25,26]. Ablation of STAT3 gene in bone marrow
cells results in overexpression of inflammatory cytokines and
dramatic expansion of myeloid cells [25]. Wang et al. [26]
have also indicated that blocking of STAT3 signaling in
tumor cells leads to secretion of inflammatory cytokines,
which can activate innate immune cells against tumor cells.
In contrast, constitutive STAT3 signaling in tumor cells inhibits
Figure 5. Western blot analysis of the activity of (A) PKR and (B) p38-MAPK
pathways in EBV-infected nasopharyngeal epithelial cells with antibodies
specific for the phosphorylated forms of eIF-2a, PKR, and p38-MAPK.
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the production of multiple proinflammatory mediators and
induces the production of pleiotropic factors that inhibit the
maturation of dendritic cells [26]. Additionally, STAT3 signal-
ing can induce the expression of SOCS (suppressor of cyto-
kine signaling) proteins, which are negative regulators of
cytokine-induced STAT activity [27]. It seems, however, that
the increased expression of SOCS1 and SOCS3 observed in
this study did not result in the suppression of STAT3 activity in
EBV-infected cells. A study of T-cell lymphoma has shown
that constitutive SOCS3 expression blocks IFN-a–mediated
growth inhibition without affecting STAT3 activation. SOCS3
was also suggested to be a protector of tumor cells [28].
Thus, the increased activation of STAT3 as well as the expres-
sion of SOCS1 and SOCS3 by EBV in NPC cells may protect
tumor cells from innate and adaptive immune responses.
p38-MAPK is a stress-dependent kinase that is also asso-
ciated with the induction of inflammatory cytokines. Further-
more, PKR is a key mediator of the antiviral effect of IFN-a. It
is also responsible for IFN synthesis and signaling. Our
recent study of EBER expression in NP69 cells has shown
that EBER is able to suppress the activation of PKR and
p38-MAPK [29]. Here, in EBV latently infected nasopharyn-
geal epithelial cells in which EBER was expressed, we ob-
served suppression of p38-MAPK activity and failure to
activate the PKR/eIF-2a pathway, both possibly associated
with the expression of EBER. Accordingly, EBV may confer
protection to latently infected nasopharyngeal epithelial cells
(especially the infected neoplastic cells) from immune attack,
thus facilitating tumor development. This possibility is still
under investigation.
Overall, this study reports our observations on important
cellular signaling cascades that are affected by EBV latent
infection in nasopharyngeal epithelial cells. The current find-
ings suggest that the activation of STAT3 and NFnB, as well
as the suppression of p38-MAPK, is crucial for EBV to pro-
tect infected cells from immunologic attack and to facilitate
cancer development.
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